First-ever withdrawal drug could vault more patients into MAT
Updated: Mar 27
FDA chief: First-ever withdrawal drug could vault more patients into addiction therapy
By Angus Liu
Patients who go off opioid painkillers face excruciating withdrawal symptoms such as anxiety, nausea, vomiting, insomnia, muscle aches and more. Now, thanks to an FDA approval for US WorldMeds' Lucemyra, they'll have the first drug designed to fight those symptoms.
Read article: https://www.fiercepharma.com/pharma/fda-approves-lucemyra-first-med-to-ease-symptoms-opioid-withdrawal